middl
east
respiratori
syndrom
coronaviru
merscov
first
recogn
caus
sever
acut
respiratori
infect
kingdom
saudi
arabia
februari
laboratoryconfirm
case
report
world
health
organ
includ
least
death
merscov
affect
countri
major
case
report
middl
east
transmiss
commonli
associ
nosocomi
outbreak
occasion
due
animaltohuman
commonli
cameltohuman
transmiss
sporad
humantohuman
transmiss
commun
although
number
symptomat
case
result
secondari
tertiari
transmiss
human
popul
appear
limit
littl
known
potenti
humantohuman
spread
among
asymptomat
minim
symptomat
individu
major
merscov
infect
observ
adult
slight
male
predomin
older
adult
comorbid
diabet
renal
diseas
respiratori
diseas
immunosuppress
commonli
repres
among
sever
ill
exhibit
mild
symptom
asymptomat
true
incid
symptomat
asymptomat
merscov
case
remain
unclear
mild
asymptomat
case
may
misdiagnos
lead
underreport
misclassif
diseas
may
also
result
possibl
detect
bia
depend
type
health
facilityunit
patient
seek
treatment
health
care
worker
appear
increas
risk
infect
merscov
like
mediat
inadequ
infect
prevent
control
ipc
measur
amplif
case
amidst
nosocomi
outbreak
incub
period
rang
day
major
symptomat
patient
present
fever
chill
cough
dyspnea
approxim
onethird
myalgia
malais
gastrointestin
symptom
among
sever
ill
promin
clinic
manifest
acut
rapidli
progress
viral
pneumonia
pneumon
lead
hypox
lung
injuri
acut
respiratori
distress
syndrom
becom
sever
ill
median
time
onset
symptom
intens
care
unit
icu
admiss
day
approxim
half
known
adult
symptomat
patient
admit
icu
requir
mechan
ventil
need
rescu
oxygen
ventil
therapi
extracorpor
membran
oxygen
high
frequenc
oscillatori
prone
ventil
renal
replac
therapi
requir
mani
critic
ill
patient
howev
incid
renal
failur
may
overestim
due
nosocomi
outbreak
involv
patient
preexist
renal
diseas
anoth
hospit
outbreak
epidemiolog
relat
renal
dysfunct
report
case
circulatori
shock
requir
intraven
vasoact
medic
describ
mani
critic
ill
patient
although
commonli
observ
sever
neurolog
syndrom
character
vari
degre
conscious
ataxia
focal
motor
deficit
bilater
hyperintens
lesion
describ
patient
merscov
isol
cerebrospin
fluid
brain
tissu
patient
infect
viru
radiolog
evid
suggest
merscov
associ
vasculopathi
may
underli
caus
communityand
nosocomialacquir
bacteri
viral
coinfect
report
patient
sever
ill
associ
increas
mortal
underscor
import
prevent
measur
need
consid
broad
rang
pathogen
treat
patient
either
suspect
confirm
merscov
liver
inflamm
evidenc
elev
aspart
aminotransferas
alanin
aminotransferas
level
common
especi
among
critic
ill
laboratori
find
includ
lymphopenia
leukopenia
well
renal
injuri
coagulopathi
patient
sever
ill
multisystem
organ
dysfunct
chest
comput
tomographi
typic
reveal
unilater
bilater
infiltr
groundglass
opac
occasion
pleural
effus
intralobular
thicken
consist
acut
respiratori
distress
syndrom
viral
pneumon
among
patient
median
time
symptom
onset
death
day
rang
day
median
length
stay
hospit
day
rang
day
higher
viral
load
determin
upper
respiratori
tract
associ
increas
sever
diseas
admiss
icu
increas
mortal
sinc
specif
treatment
proven
effect
merscov
case
manag
larg
reli
organsupport
therapi
prevent
complic
coinfect
treat
specif
antimicrobi
antivir
medic
potenti
agent
treat
merscov
infect
deriv
experi
noninfluenza
respiratori
viral
infect
includ
sever
acut
respiratori
syndrom
sar
case
studi
report
outcom
patient
treat
oral
ribavirin
interferon
howev
studi
high
risk
select
bia
confound
indic
inclus
patient
larg
depend
sever
ill
nonrandom
alloc
separ
influenc
mani
potenti
confound
condit
cointervent
previou
studi
may
also
affect
immort
time
bia
patient
need
remain
aliv
long
enough
receiv
particular
therapi
form
bia
confound
variabl
preclud
valid
estim
true
treatment
effect
current
phase
ii
openlabel
singl
group
assign
safetyefficaci
studi
convalesc
plasma
therapi
plasma
deriv
survivor
merscov
infect
underway
king
abdullah
intern
medic
research
center
saudi
arabia
expect
complet
june
recombin
modifi
vaccinia
viru
ankara
vaccin
express
fulllength
merscov
spike
glycoprotein
develop
prevent
purpos
endors
german
center
infect
research
difz
phase
clinic
trial
human
howev
yet
human
data
regard
potenti
effect
vaccin
littl
known
longterm
outcom
patient
merscov
howev
accord
largest
cohort
confirm
merscov
patient
n
intub
receiv
invas
mechan
ventil
n
recov
acut
infect
complic
surviv
one
year
followup
period
short
time
sinc
merscov
discov
signific
progress
made
understand
epidemiolog
pathophysiolog
clinic
manifest
potenti
treatment
option
howev
mani
import
question
remain
although
exposur
camel
implic
human
merscov
case
potenti
anim
reservoir
yet
identifi
effect
treatment
vaccin
also
yet
develop
sporad
natur
merscov
outbreak
collabor
research
effort
across
affect
countri
necessari
better
assess
potenti
anim
reservoir
epidemiolog
risk
factor
transmiss
merscov
develop
control
ideal
blind
treatment
evalu
research
protocol
data
collect
tool
prepar
vet
approv
preposit
across
middl
east
elsewher
facilit
time
implement
research
activ
close
mani
remain
knowledg
gap
fund
sourc
none
declar
requir
mikiko
senga
staff
member
world
health
organ
author
alon
respons
view
express
articl
necessarili
repres
decis
polici
view
world
health
organ
